Ute Reuning - Concepedia

Author

Ute Reuning

Technical University of Munich ORCID

Also Known As

U Reuning, U. Reuning, Ute Reuning

137

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Technical University of Munich Klinikum rechts der Isar Institute for Advanced Study München Klinik Ludwig-Maximilians-Universität München

About

Ute Reuning is an author at Technical University of Munich specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.5K
2	Natural Sciences	8	8	168
3	Health Sciences	4	4	147
4	Biochemistry	4	4	77
5	Engineering	3	3	129

Ute Reuning

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins Tobias G. Kapp, Florian Rechenmacher, Stefanie Neubauer, Scientific Reports	2017	570
Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy Manfred Schmitt, Nadia Harbeck, Christoph Thomssen, Thrombosis and Haemostasis Tumor BiologyTumor InvasionTumoral PathologyMedicineCancer Invasion	1997	387
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. Roland Haubner, Hans‐Jürgen Wester, Ute Reuning, PubMed	1999	356
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer Holger Bronger, J. David Singer, Claudia Windmüller, British Journal of Cancer	2016	257
Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes Haissi Cui, Bastian Seubert, Elizabeth C. Stahl, Oncogene Tumor BiologyLung Adenocarcinoma CellsMetalloproteinases-1 InducesMedicineTissue Inhibitor	2014	190
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc W. Kühn, Barbara Schmalfeldt, Ute Reuning, British Journal of Cancer	1999	130
The urokinase plasminogen activator system as a novel target for tumour therapy Manfred Schmitt, Olaf G. Wilhelm, Ute Reuning, Fibrinolysis & proteolysis/Fibrinolysis and proteolysis Drug TargetingNovel TherapyTumour TherapyMedicineNovel Target	2000	108
Monitoring of integrin-mediated adhesion of human ovarian cancer cells to model protein surfaces by quartz crystal resonators: evaluation in the impedance analysis mode Jing Li, Christiane Thielemann, Ute Reuning, Biosensors and Bioelectronics EngineeringBiomedical DiagnosticsMedicineCell AdhesionCell-matrix Interaction	2004	98
Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. Barbara Schmalfeldt, W. Kühn, Ute Reuning, PubMed UrologySurgical OncologyEndocrine-related CancerGenitourinary CancerMedicine	1995	94
β-Catenin Up-Regulates the Expression of the Urokinase Plasminogen Activator in Human Colorectal Tumors Elke Hiendlmeyer, Susanne Regus, Stella Wassermann, Cancer Research	2004	85

Page 1